Click for best price
Sustained Release Ocular Drug Delivery Systems Market Size, Share 2022
This report contains market size and forecasts of Sustained Release Ocular Drug Delivery Systems in global, including the following market information:
Global Sustained Release Ocular Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sustained Release Ocular Drug Delivery Systems Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Sustained Release Ocular Drug Delivery Systems companies in 2021 (%)
The global Sustained Release Ocular Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposome Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sustained Release Ocular Drug Delivery Systems include pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics and GrayBug, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sustained Release Ocular Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sustained Release Ocular Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
Global Sustained Release Ocular Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Cataract
Glaucoma
Corneal Transplantation
Others
Global Sustained Release Ocular Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sustained Release Ocular Drug Delivery Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sustained Release Ocular Drug Delivery Systems revenues share in global market, 2021 (%)
Key companies Sustained Release Ocular Drug Delivery Systems sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Sustained Release Ocular Drug Delivery Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
| Report Attributes |
Report Details |
| Report Title |
Sustained Release Ocular Drug Delivery Systems Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sustained Release Ocular Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sustained Release Ocular Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sustained Release Ocular Drug Delivery Systems Overall Market Size
2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sustained Release Ocular Drug Delivery Systems Sales: 2017-2028
3 Company Landscape
3.1 Top Sustained Release Ocular Drug Delivery Systems Players in Global Market
3.2 Top Global Sustained Release Ocular Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Sustained Release Ocular Drug Delivery Systems Revenue by Companies
3.4 Global Sustained Release Ocular Drug Delivery Systems Sales by Companies
3.5 Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sustained Release Ocular Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Sustained Release Ocular Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sustained Release Ocular Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Liposome
4.1.3 Microcapsules/Nanocapsules
4.1.4 Microspheres/Nanosptheres
4.1.5 Implants
4.2 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
4.3 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
4.3.1 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales, 2017-2022
4.3.2 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales, 2023-2028
4.3.3 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
4.4 By Type - Global Sustained Release Ocular Drug Delivery Systems Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Sustained Release Ocular Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 Cataract
5.1.3 Glaucoma
5.1.4 Corneal Transplantation
5.1.5 Others
5.2 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
5.3 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
5.3.1 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales, 2017-2022
5.3.2 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales, 2023-2028
5.3.3 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
5.4 By Application - Global Sustained Release Ocular Drug Delivery Systems Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Sustained Release Ocular Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
6.3.1 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales, 2017-2022
6.3.2 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales, 2023-2028
6.3.3 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2028
6.4.2 By Country - North America Sustained Release Ocular Drug Delivery Systems Sales, 2017-2028
6.4.3 US Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.4.4 Canada Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.4.5 Mexico Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2028
6.5.2 By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales, 2017-2028
6.5.3 Germany Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5.4 France Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5.5 U.K. Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5.6 Italy Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5.7 Russia Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5.8 Nordic Countries Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.5.9 Benelux Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2028
6.6.2 By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales, 2017-2028
6.6.3 China Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.6.4 Japan Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.6.5 South Korea Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.6.6 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.6.7 India Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2028
6.7.2 By Country - South America Sustained Release Ocular Drug Delivery Systems Sales, 2017-2028
6.7.3 Brazil Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.7.4 Argentina Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, 2017-2028
6.8.3 Turkey Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.8.4 Israel Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.8.5 Saudi Arabia Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
6.8.6 UAE Sustained Release Ocular Drug Delivery Systems Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 pSivida
7.1.1 pSivida Corporate Summary
7.1.2 pSivida Business Overview
7.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.1.5 pSivida Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.2.5 Allergan Key News
7.3 Icon Bioscience
7.3.1 Icon Bioscience Corporate Summary
7.3.2 Icon Bioscience Business Overview
7.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.3.5 Icon Bioscience Key News
7.4 Ocular Therapeutix
7.4.1 Ocular Therapeutix Corporate Summary
7.4.2 Ocular Therapeutix Business Overview
7.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.4.5 Ocular Therapeutix Key News
7.5 Neurotech Pharmaceuticals
7.5.1 Neurotech Pharmaceuticals Corporate Summary
7.5.2 Neurotech Pharmaceuticals Business Overview
7.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.5.5 Neurotech Pharmaceuticals Key News
7.6 Santen Pharmaceutical
7.6.1 Santen Pharmaceutical Corporate Summary
7.6.2 Santen Pharmaceutical Business Overview
7.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.6.5 Santen Pharmaceutical Key News
7.7 Aciont Inc.
7.7.1 Aciont Inc. Corporate Summary
7.7.2 Aciont Inc. Business Overview
7.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.7.5 Aciont Inc. Key News
7.8 Envisia Therapeutics
7.8.1 Envisia Therapeutics Corporate Summary
7.8.2 Envisia Therapeutics Business Overview
7.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.8.5 Envisia Therapeutics Key News
7.9 GrayBug
7.9.1 GrayBug Corporate Summary
7.9.2 GrayBug Business Overview
7.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.9.5 GrayBug Key News
7.10 Innocore Pharmaceuticals
7.10.1 Innocore Pharmaceuticals Corporate Summary
7.10.2 Innocore Pharmaceuticals Business Overview
7.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.10.5 Innocore Pharmaceuticals Key News
7.11 OHR Pharmaceuticals
7.11.1 OHR Pharmaceuticals Corporate Summary
7.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Business Overview
7.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.11.5 OHR Pharmaceuticals Key News
7.12 PolyActiva
7.12.1 PolyActiva Corporate Summary
7.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Business Overview
7.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.12.5 PolyActiva Key News
7.13 TheraKine
7.13.1 TheraKine Corporate Summary
7.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Business Overview
7.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.13.5 TheraKine Key News
8 Global Sustained Release Ocular Drug Delivery Systems Production Capacity, Analysis
8.1 Global Sustained Release Ocular Drug Delivery Systems Production Capacity, 2017-2028
8.2 Sustained Release Ocular Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Sustained Release Ocular Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sustained Release Ocular Drug Delivery Systems Supply Chain Analysis
10.1 Sustained Release Ocular Drug Delivery Systems Industry Value Chain
10.2 Sustained Release Ocular Drug Delivery Systems Upstream Market
10.3 Sustained Release Ocular Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sustained Release Ocular Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Sustained Release Ocular Drug Delivery Systems in Global Market
Table 2. Top Sustained Release Ocular Drug Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sustained Release Ocular Drug Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Companies, 2017-2022
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Sustained Release Ocular Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2017-2022
Table 15. By Type - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2017-2022
Table 20. By Application - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2017-2022
Table 25. By Region - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2023-2028
Table 26. By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2023-2028
Table 46. pSivida Corporate Summary
Table 47. pSivida Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 48. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Allergan Corporate Summary
Table 50. Allergan Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 51. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Icon Bioscience Corporate Summary
Table 53. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 54. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Ocular Therapeutix Corporate Summary
Table 56. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 57. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Neurotech Pharmaceuticals Corporate Summary
Table 59. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 60. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Santen Pharmaceutical Corporate Summary
Table 62. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 63. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Aciont Inc. Corporate Summary
Table 65. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 66. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Envisia Therapeutics Corporate Summary
Table 68. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 69. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. GrayBug Corporate Summary
Table 71. GrayBug Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 72. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Innocore Pharmaceuticals Corporate Summary
Table 74. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 75. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. OHR Pharmaceuticals Corporate Summary
Table 77. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 78. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. PolyActiva Corporate Summary
Table 80. PolyActiva Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 81. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. TheraKine Corporate Summary
Table 83. TheraKine Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 84. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Sustained Release Ocular Drug Delivery Systems Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 86. Global Sustained Release Ocular Drug Delivery Systems Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Sustained Release Ocular Drug Delivery Systems Production by Region, 2017-2022 (K Pcs)
Table 88. Global Sustained Release Ocular Drug Delivery Systems Production by Region, 2023-2028 (K Pcs)
Table 89. Sustained Release Ocular Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 90. Sustained Release Ocular Drug Delivery Systems Market Drivers in Global Market
Table 91. Sustained Release Ocular Drug Delivery Systems Market Restraints in Global Market
Table 92. Sustained Release Ocular Drug Delivery Systems Raw Materials
Table 93. Sustained Release Ocular Drug Delivery Systems Raw Materials Suppliers in Global Market
Table 94. Typical Sustained Release Ocular Drug Delivery Systems Downstream
Table 95. Sustained Release Ocular Drug Delivery Systems Downstream Clients in Global Market
Table 96. Sustained Release Ocular Drug Delivery Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Segment by Type
Figure 2. Sustained Release Ocular Drug Delivery Systems Segment by Application
Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sustained Release Ocular Drug Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sustained Release Ocular Drug Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. Sustained Release Ocular Drug Delivery Systems Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Sustained Release Ocular Drug Delivery Systems Revenue in 2021
Figure 9. By Type - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 10. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 13. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 16. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 19. US Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 24. Germany Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. France Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 33. China Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. India Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 40. Brazil Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2017-2028
Figure 44. Turkey Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sustained Release Ocular Drug Delivery Systems Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Sustained Release Ocular Drug Delivery Systems by Region, 2021 VS 2028
Figure 50. Sustained Release Ocular Drug Delivery Systems Industry Value Chain
Figure 51. Marketing Channels
